Literature DB >> 9914383

Inhibition of the Mr 70,000 S6 kinase pathway by rapamycin results in chromosome malsegregation in yeast and mammalian cells.

S Bonatti1, M Simili, A Galli, P Bagnato, S Pigullo, R H Schiestl, A Abbondandolo.   

Abstract

The antifungal and immunosuppressive drug rapamycin arrests the cell cycle in G1-phase in both yeast and mammalian cells. In mammalian cells, rapamycin selectively inhibits phosphorylation and activation of p70 S6 kinase (p70(S6K)), a protein involved in the translation of a subset of mRNAs, without affecting other known kinases. We now report that rapamycin causes chromosome malsegregation in mammalian and yeast cells. Chromosome malsegregation was determined by metaphase chromosome analysis of human lymphocytes and lymphoblasts, detection of CREST-positive micronuclei in human lymphoblasts and Chinese hamster embryonic fibroblast (CHEF) cells, and selection of doubly prototrophic cells in a specially constructed yeast strain. The number of ana-telophases with displaced chromosomes and interphase and mitotic cells with an irregular number of centrosomes was also determined in CHEF cells. In quiescent mammalian cells (human lymphocytes and CHEF cells) induced with growth factor to re-enter the cell cycle, rapamycin was effective when cells were exposed at the time of p70(S6K) activation. In yeast, rapamycin was more effective when treatment was started in G1- than in G2-synchronized cells. Cells from ataxia telangiectasia (A-T) patients are characterized by chromosome instability and have recently been found to be resistant to the growth-inhibiting effect of rapamycin. We found that an A-T lymphoblastoid cell line was also resistant to the induction of chromosome malsegregation by rapamycin, but the level of spontaneous aneuploidy was higher than in normal cells. In yeast, the induction of chromosome malsegregation was dependent on the presence of a wild-type TUB2 gene, encoding the beta-subunit of tubulin. The finding that rapamycin acts in different cell types and organisms suggests that the drug affects a conserved step important for proper segregation of chromosomes. One or more proteins required for chromosome segregation could be under the control of the rapamycin-sensitive pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9914383     DOI: 10.1007/s004120050335

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  6 in total

1.  Arabidopsis S6 kinase mutants display chromosome instability and altered RBR1-E2F pathway activity.

Authors:  Rossana Henriques; Zoltán Magyar; Antonia Monardes; Safina Khan; Christine Zalejski; Juan Orellana; László Szabados; Consuelo de la Torre; Csaba Koncz; László Bögre
Journal:  EMBO J       Date:  2010-08-03       Impact factor: 11.598

2.  A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR).

Authors:  T F Chan; J Carvalho; L Riles; X F Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

3.  Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.

Authors:  J Liu; T D Prickett; E Elliott; G Meroni; D L Brautigan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

4.  mTOR controls ovarian follicle growth by regulating granulosa cell proliferation.

Authors:  James Yu; Aylin Yaba; Corinna Kasiman; Travis Thomson; Joshua Johnson
Journal:  PLoS One       Date:  2011-07-05       Impact factor: 3.240

5.  Regulation of 4E-BP1 activity in the mammalian oocyte.

Authors:  Denisa Jansova; Marketa Koncicka; Anna Tetkova; Renata Cerna; Radek Malik; Edgar Del Llano; Michal Kubelka; Andrej Susor
Journal:  Cell Cycle       Date:  2017-03-08       Impact factor: 4.534

6.  TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells.

Authors:  Chihiro Yamada; Aya Morooka; Seira Miyazaki; Masayoshi Nagai; Satoru Mase; Kenji Iemura; Most Naoshia Tasnin; Tsuneyuki Takuma; Shotaro Nakamura; Shamsul Morshed; Naoki Koike; Md Golam Mostofa; Muhammad Arifur Rahman; Tasnuva Sharmin; Haruko Katsuta; Kotaro Ohara; Kozo Tanaka; Takashi Ushimaru
Journal:  iScience       Date:  2021-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.